Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-615-5858
Fax+1 215-615-3349
Dr. Bauml is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2011 - 2014
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2008 - 2011- Icahn School of Medicine at Mount SinaiClass of 2008
Certifications & Licensure
PA State Medical License 2011 - 2026
NY State Medical License 2009 - 2011
Clinical Trials
- Acupuncture Feasibility Trial for Dyspnea in Lung Cancer Start of enrollment: 2014 Mar 01
- Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer Start of enrollment: 2018 Jun 18
Publications & Presentations
PubMed
- Plain language summary of first-line amivantamab-lazertinib in previously untreated high-risk EGFR-altered non-small-cell lung cancer in MARIPOSA.Enriqueta Felip, Byoung Chul Cho, Shun Lu, Mehmet Ali Nahit Şendur, Shirish M Gadgeel
Future Oncology. 2025-04-24 - Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials.David E Gerber, Claire R Wynters, Tanushree Prasad, Ronny K Schnel, Song Zhang
Clinical Cancer Research. 2025-03-17 - Preventing Infusion-Related Reactions With Intravenous Amivantamab-Results From SKIPPirr, a Phase 2 Study: A Brief Report.Alexander I Spira, Luis Paz-Ares, Ji-Youn Han, Jin-Yuan Shih, Céline Mascaux
Journal of Thoracic Oncology. 2025-01-24
Journal Articles
- Oncologic Outcomes Following Transoral Robotic Surgery for Human Papillomavirus–Associated Oropharyngeal Carcinoma in Older PatientsHarman S Parhar, Karthik Rajasekaran, Ara A Chalian, Christopher H Rassekh, Roger B Cohen, Joshua Bauml, Gregory S Weinstein, Robert M Brody, JAMA Otolaryngology–Head & Neck Surgery
- Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs DataRavi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
- Immunotherapy Targeting HPV 16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck CancerGregory S Weinstein, Charu Aggarwal, Roger B Cohen, Joshua Bauml, Alexander Lin, Clinical Cancer Research
- Join now to see all
Press Mentions
RYBREVANT® (Amivantamab-Vmjw) plus LAZCLUZE™ (Lazertinib) Outperforms Osimertinib with a Significant and Unprecedented Overall Survival Benefit in Patients with EGFR-Mutated Non-Small Cell Lung CancerMarch 26th, 2025- CHMP Recommends Subcutaneous RYBREVANT®▼ (Amivantamab) for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung CancerFebruary 2nd, 2025
- RYBREVANT®▼ (Amivantamab) plus Chemotherapy Shows Positive Overall Survival Trend Versus Chemotherapy in Patients with Previously Treated EGFR-Mutated Lung CancerSeptember 16th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Gold Humanism Honor SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
